back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-07-06 12:04 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Greven, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2026-07-06 12:00 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Greven, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
||
| Filed 2026-07-06 11:58 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Greven, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2026-07-06 11:58 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Greven, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
||
| Filed 2026-07-06 11:56 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Greven, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
||
| Filed 2026-07-06 11:56 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Greven, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
||
| Filed 2026-07-06 11:45 Tx date 2025-06-25 |
$KNE
Kane Biotech Inc. |
Greven, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-03 14:16 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+4,000,000 vol $0.05 each |
4,000,000 | |
| Filed 2026-06-03 14:12 Tx date 2024-02-21 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-02 21:08 Tx date 2026-06-02 |
$KNE
Kane Biotech Inc. |
Christofalos, Lori Marlene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,500,000 vol |
1,500,000 | |
| Filed 2026-06-02 21:00 Tx date 2024-03-01 |
$KNE
Kane Biotech Inc. |
Christofalos, Lori Marlene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-01 12:28 Tx date 2025-03-11 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-62,500 vol |
0 | |
| Filed 2026-06-01 12:02 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Rampertab, Shameze
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2026-06-01 11:51 Tx date 2025-06-25 |
$KNE
Kane Biotech Inc. |
Rampertab, Shameze
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-01 11:30 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,750,000 vol |
1,750,000 | |
| Filed 2026-06-01 08:25 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2026-06-01 08:19 Tx date 2025-06-25 |
$KNE
Kane Biotech Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-28 14:47 Tx date 2025-06-26 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$1,000,000 vol $0.10 each |
$1,000,000 | |
| Filed 2026-05-28 14:33 Tx date 2010-09-15 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-28 14:30 Tx date 2026-05-25 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$1,200,000
+20,000,000 vol $0.06 each |
20,000,000 |